AEM Holdings Is Up 6x This Year. Do the Numbers Justify It?

Let me start with the question that matters: after a 6x run, is AEM still worth buying, or are you paying for a story already in the price?

First the data. 1Q26 revenue came in at S$116.9 million, up 35.8% year on year. Net profit was up 329%, and net margin expanded from 3.9% to 12.3%. That margin jump is the key number, because it shows the growth is operating leverage, not just topline. Test Cell Solutions grew 72% to S$88.1 million, now over three quarters of the group. Management raised FY26 guidance about 20% to S$550 to 600 million.

Why this matters. AEM is a system level test leader, roughly one generation ahead of competitors, and AI chips need far more test coverage than older chips. That is a structural tailwind, not a one quarter spike. The new fabless AI/HPC customer becoming the largest contributor in 2026 also reduces the old Intel concentration risk.

The risk is valuation and visibility. After 6x, the stock prices in a lot. Analyst targets diverge sharply, with one as high as S$11.80 and the consensus well below the recent price. When targets are this far apart, earnings visibility is low and the next guidance update moves the stock hard.

My take: the business quality has genuinely improved and I am constructive on the multi year test demand story. But after this run I would not chase it here. I would rather wait for a pullback or for the memory ramp to show up in actual revenue. Great company, demanding price. As always, not investment advice.